Researchers identify new targets that could make paclitaxel more effective
This article was originally published in Scrip
Executive Summary
Manufacturers of the chemotherapy drug paclitaxel will be interested in new findings that could eventually make the drug more effective in lower concentrations, according to a new study. Discussions with companies on how to take potential new targets forward are welcome, said Dr Ahmed Ahmed from Oxford University, lead researcher of the team behind the discovery.